McGill University Health Centre/Research Institute of the McGill University Health Centre
538
102
123
214
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
7.8%
42 terminated/withdrawn out of 538 trials
83.6%
-3.0% vs industry average
16%
86 trials in Phase 3/4
9%
20 of 214 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (538)
The CANadian EXAcerbation of COPD Trial
Role: lead
Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
Role: lead
Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery
Role: collaborator
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Role: lead
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Role: lead
Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
Role: collaborator
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
Role: collaborator
Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia
Role: lead
Effect of High Dose Insulin on Infectious Complications Following Major Surgery
Role: lead
Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness
Role: collaborator
Fetal Brain Growth - Pilot Study
Role: lead
Behavioural Test for Early Glaucoma
Role: lead
Detection of Respiratory Events Using Acoustic Monitoring in Extremely Preterm Infants
Role: lead
Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men
Role: collaborator
Effect of Dairy Products on Insulin Resistance
Role: lead
Detection of Infant GastrointEstinal Activity Using Sound Technology
Role: lead
Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine
Role: collaborator
Miniaturized Vital Sign Monitoring for Newborns in the Delivery Room
Role: lead
This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.
Role: lead
Validation of a Wireless Wearable Vital Signs Monitor in Pediatric Patient
Role: lead